Martin C. Whittle

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Sunil R. Hingorani · 5 shared papers, 2015–2026 · strength 0.66
   • Paper Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Me… DOI 10.3390/cancers18030507↗
   • Paper Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets. DOI 10.1053/j.gastro.2018.12.044↗
   • Paper RUNX3 defines disease behavior in pancreatic ductal adenocarcinoma. DOI 10.1080/23723556.2015.1076588↗
2. Andrew Eugene Hendifar · 1 shared paper, 2026 · strength 0.23
   • Paper Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Me… DOI 10.3390/cancers18030507↗
3. Ben George · 1 shared paper, 2026 · strength 0.23
   • Paper Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Me… DOI 10.3390/cancers18030507↗
4. Andrew L. Coveler · 1 shared paper, 2026 · strength 0.23
   • Paper Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Me… DOI 10.3390/cancers18030507↗
5. Sita Kugel · 1 shared paper, 2026 · strength 0.23
   • Paper Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Me… DOI 10.3390/cancers18030507↗
6. Tomislav Dragovich · 1 shared paper, 2026 · strength 0.23
   • Paper Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Me… DOI 10.3390/cancers18030507↗
7. Rachael Ann Safyan · 1 shared paper, 2026 · strength 0.23
   • Paper Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Me… DOI 10.3390/cancers18030507↗
8. David Bing Zhen · 1 shared paper, 2026 · strength 0.23
   • Paper Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Me… DOI 10.3390/cancers18030507↗
9. Elena Gabriela Chiorean · 1 shared paper, 2026 · strength 0.23
   • Paper Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Me… DOI 10.3390/cancers18030507↗
10. Howard S. Höchster · 1 shared paper, 2026 · strength 0.23
    • Paper Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Me… DOI 10.3390/cancers18030507↗
11. Alvin P. Makohon-Moore · 1 shared paper, 2017 · strength 0.06
    • Paper Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cance… DOI 10.1158/1078-0432.ccr-15-1615↗
12. Brian T. Herbst · 1 shared paper, 2017 · strength 0.06
    • Paper Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cance… DOI 10.1158/1078-0432.ccr-15-1615↗
13. Yi Zhong · 1 shared paper, 2017 · strength 0.06
    • Paper Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cance… DOI 10.1158/1078-0432.ccr-15-1615↗
14. Zachary A. Kohutek · 1 shared paper, 2017 · strength 0.06
    • Paper Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cance… DOI 10.1158/1078-0432.ccr-15-1615↗
15. Steven D Leach · 1 shared paper, 2017 · strength 0.06
    • Paper Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cance… DOI 10.1158/1078-0432.ccr-15-1615↗
16. Christine A. Iacobuzio–Donahue · 1 shared paper, 2017 · strength 0.06
    • Paper Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cance… DOI 10.1158/1078-0432.ccr-15-1615↗
17. Kathleen E. DelGiorno · 1 shared paper, 2015 · strength 0.04
    • Paper RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.cell.2015.04.048↗
18. Amy E. Chang · 1 shared paper, 2015 · strength 0.04
    • Paper RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.cell.2015.04.048↗
19. Laura DeLong Wood · 1 shared paper, 2015 · strength 0.04
    • Paper RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.cell.2015.04.048↗
20. Michael Goggins · 1 shared paper, 2015 · strength 0.04
    • Paper RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.cell.2015.04.048↗
21. Ralph H. Hruban · 1 shared paper, 2015 · strength 0.04
    • Paper RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma. DOI 10.1016/j.cell.2015.04.048↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.